RxCelerate
Matthew Earl is an experienced professional in the field of chemistry, currently serving as Chemistry Project Leader and Senior Scientific Officer at RXCELERATE LIMITED since November 2019. Prior experience includes a role as Postgraduate Researcher at the University of Warwick from October 2015 to December 2019, where Matthew completed a PhD under Dr. David Fox, focusing on the synthesis and reactions of Indan-1-ones for medicinal applications. Matthew also demonstrated leadership skills as President of Warwick Volunteers and Project Leader for Technology Volunteers, overseeing initiatives aimed at teaching technology to children in the local community. Additionally, Matthew acquired practical experience as a Process Chemist during an industrial placement at Syngenta and has a solid academic foundation, having earned an MChem degree from the University of Warwick.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!